S1600: Effects of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes: Primary Results from the Randomized Phase III Double-Blind Clinical Trial | Jill Hamilton-Reeves, Ph.D., RD, CSO | Jill Hamilton-Reeves presented the primary results of the S1600 trial at ASCO 2024, assessing the effects of immune-enhancing nutrition on outcomes for bladder cancer patients undergoing radical cystectomy. The randomized, double-blind, phase III trial compared specialized immunonutrition (fortified with L-arginine, omega-3 fatty acids, and dietary nucleotides) to standard oral nutritional support | |
|
|